NCT Number: NCT01846325
The Effects of Administration of Combined Docosahexaenoic Acid and Vitamin E Supplements on Spermatogram and Seminal Plasma Oxidative Stress in Infertile Men With Asthenozoospermia
Since docosahexaenoic acid (DHA) level in sperm membrane has been shown to be decreased in asthenozoospermic men, the investigators hypothesized that DHA supplementation may improve it. Furthermore, the investigators added vitamin E to it to protect its unsaturated bonds which are susceptible to oxidation and production of free oxygen radicals.
Looking for future studies?
Notify MeKey information
Conditions
Age range
20 year–45 year
Sex eligibility
Male
Study type
Interventional
Phase
Phase 2 / Phase 3
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Willing to participate in the study and filling out the informed consent form
- should be infertile (no conception after 12 months intercourse without any contraception)
- age 20-45 y.o, idiopathic asthenospermia according to WHO criteria
- normal hormonal profile
Exclusion criteria
- any infection in genitourinary (GU) tract
- any anatomical abnormality in GU tract
- any chronic disease during last 3 months
- any surgery in GU tract
- consumption of omega-3 fatty acids and/or vitamin E supplements during last 3 months
Treatment and study plan
DHA
Dietary SupplementPlacebo
OtherPrimary outcomes
-
sperm motility
Time frame: 12 weeks
spermatogram
Secondary outcomes
-
sperm count
Time frame: 12 weeks
spermatogram
-
seminal oxidative stress
Time frame: 12 weeks
ELISA
Sponsors and collaborators
Lead sponsor
National Nutrition and Food Technology Institute
Other
Registry information
Important dates
- Study start
- 2013
- Primary completion
- 2015
- Study completion
- 2015
- First posted
- May 3, 2013
- Registry last updated
- Jun 16, 2015
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Effect of Walnuts on Sperm Parameters and Male Fertility
NCT01954498
Asthenozoospermia, Fertility
Los Angeles, California, United States
View Trial DetailsAlpha Lipoic Acid Plus Coenzyme Q10 Versus Coenzyme Q10 Alone in Asthenozoospermia
NCT07455890
Asthenozoospermia, Genital Diseases
Dhaka, Shahbag, Bangladesh
View Trial DetailsEffect of Antioxidant Food Supplement on Sperm Proteomic Structure and Semen Parameters
NCT05826782
Asthenozoospermia, Genital Diseases
Kocaeli, Izmit, Turkey (Türkiye)
View Trial DetailsA Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of STSP-0902 in Healthy Subjects
NCT06563713
Asthenozoospermia, Genital Diseases
Beijing, Beijing Municipality, China
View Trial Details